The safety profile has been favorable through several years of real-world use
Drug companies also support the Obesity Action Coalition, an industry-backed group that says it fights weight stigma
Being sick (vomiting)
Multiple presentation of mitochondrial disorders
Adjusting for age, sex, race/ethnicity, income, education, and food security status, individuals experiencing nutrition insecurity were 40%60% more likely to have obesity as well as type 2 diabetes, heart disease, hypertension, and hypercholesterolemia
Pipeline assets like high-dose Wegovy, CagriSema, and Zenagamtide offer risk-adjusted lifecycle support but face efficacy and tolerability challenges